No, premature ventricular contractions (PVCs) and supraventricular tachycardia (SVT) are not the same. A PVC is a single early heartbeat that starts in the ventricles and usually feels like one hard thump or a skipped beat. SVT is a sustained fast rhythm that starts above the ventricles and typically runs from 150 to 250 beats per minute for seconds to hours. One is an isolated misfire, the other is a runaway circuit. They differ in origin, duration, danger, and treatment, though both can feel like a racing or pounding heart.
Where Each Rhythm Starts and Why It Feels Different
The heart's electrical system normally fires from the sinoatrial node in the right atrium. A PVC breaks that order at the bottom of the heart. An irritable patch of ventricular muscle depolarizes early, before the next scheduled signal arrives. Because the beat comes from below, it spreads cell to cell rather than through the fast conduction fibers. That makes the QRS complex wide, at 120 milliseconds or more on an ECG, versus under 120 milliseconds for a normal beat. After the early beat, the ventricle is still refractory, so the next normal beat is delayed. That pause is what most people feel as a dropped beat, even though the extra beat came first.
SVT works almost oppositely. The misfire stays above the ventricles, in the atria or the atrioventricular node. Because it still travels down the normal His-Purkinje highways, the QRS is narrow, usually under 120 milliseconds. The problem is not one stray beat but a self-sustaining loop or a rapidly firing focus. The result is a sudden, regular, fast rhythm. Onset and offset are abrupt, often described as a switch flipping on and off.
In plain terms: a PVC is one wrong note, while SVT is the orchestra playing the same bar over and over too fast.
There is a numeric bridge worth holding onto. A single PVC lasts roughly 0.12 to 0.20 seconds. An SVT episode usually lasts from several seconds to many hours, and the tachycardia itself is defined as a rate above 100 beats per minute, with most paroxysmal SVT landing between 150 and 250. One event is measured in tenths of a second, the other in minutes.
Quantified Context: How Common and How Dangerous
PVCs are extremely common and mostly benign. In population studies using 24-hour Holter monitoring, 40 to 75 percent of healthy adults show at least one PVC. Frequency rises with age: fewer than 5 percent of young adults have more than 100 PVCs in 24 hours, while that threshold is crossed by a meaningful share of people past age 60. A widely used clinical cutoff is 10 percent of total beats, roughly 10,000 PVCs per day on a 100,000-beat day, above which the risk of a PVC-induced cardiomyopathy climbs sharply.
SVT is far less common than isolated PVCs but more likely to send someone to an emergency department. Paroxysmal SVT has an estimated prevalence of about 2 to 3 per 1,000 people, and it is the most common cause of sudden palpitations in young adults without structural heart disease. Atrioventricular nodal reentrant tachycardia, the most frequent SVT subtype, accounts for roughly 60 percent of cases and often first appears between ages 20 and 40.
The comparison sharpens when you look at outcomes. Frequent PVCs in a structurally normal heart carry a low annual risk of serious events, but a PVC burden above 15 to 20 percent raises cardiomyopathy risk enough to justify catheter ablation. SVT, by contrast, is rarely life-threatening in a normal heart, yet a sustained rate above 200 beats per minute can cause fainting or, in people with pre-existing coronary disease, provoke ischemia. The danger profile is different in kind, not just degree.
Head-to-Head Comparison
| Feature | PVC | SVT |
|---|---|---|
| Origin | Ventricles (below the AV node) | Atria or AV node (above the ventricles) |
| Typical QRS width | 120 ms or wider | Under 120 ms (narrow) |
| Rhythm pattern | Isolated early beat, then compensatory pause | Sustained regular fast rhythm |
| Typical rate | Single beat; underlying rate unchanged | 150 to 250 beats per minute |
| Duration | 0.12 to 0.20 seconds per beat | Seconds to hours |
| Onset and offset | Abrupt single event | Abrupt, often sudden start and stop |
| Most common sensation | One hard thump or skipped beat | Racing, fluttering, pounding chest |
| Prevalence | 40 to 75 percent of adults on 24-hour monitoring | About 2 to 3 per 1,000 people |
| First-line approach | Reassurance if infrequent and heart is normal | Vagal maneuvers, then adenosine or beta-blockers |
| Definitive fix for symptomatic cases | Catheter ablation if burden is high | Catheter ablation, success above 90 percent |
The single most useful discriminator is duration plus QRS width. A person who feels one thump every few minutes almost certainly has PVCs. A person whose heart suddenly pounds at 180 for ten minutes has SVT until proven otherwise. The two can coexist: PVCs can trigger SVT, and SVT can end with a PVC. Coexistence is why an ECG, not a symptom description, settles the question.
Edge Cases That Blur the Line
Two specific scenarios routinely confuse clinicians and patients. The first is a run of consecutive PVCs, called a ventricular couplet or, at three or more, non-sustained ventricular tachycardia. A short burst of wide-complex beats at 150 per minute looks like tachycardia and is tachycardia, but it originates in the ventricle. That distinction matters because ventricular tachycardia carries higher risk than SVT and is treated differently.
The second is SVT with aberrant conduction. When an SVT conducts down a bundle branch that is partially blocked, the QRS widens and mimics a ventricular rhythm on the monitor. A practiced eye looks for the relationship between atrial and ventricular activity, but the practical caveat is this: any wide-complex fast rhythm is treated as ventricular until a clinician proves otherwise, because the cost of being wrong is high. That is a professional rule of thumb, not a rigid law.
A third edge case is the PVC burden threshold itself. The 10 percent and 15 to 20 percent figures are not interchangeable, and reconciling them matters: 10 percent of beats is roughly 10,000 PVCs in 24 hours, the level at which cardiomyopathy risk becomes clinically relevant and monitoring is warranted, whereas 15 to 20 percent is the burden at which ablation is generally recommended in otherwise unexplained heart failure. The lower number triggers investigation; the higher number triggers intervention.
Common Misconceptions, Corrected
The most persistent misconception is that a skipped beat means the heart stopped. It did not. The early PVC resets the timing, and the pause afterward is the ventricle refilling. The heart never actually missed a scheduled contraction; the schedule was overwritten.
A second misconception is that PVCs are always harmless. They are harmless in most people with a normal heart, but a burden above 10 percent or symptoms that limit daily life are signals to see a cardiologist. Frequency, not the sensation, is what separates benign from concerning.
A third is that SVT and atrial fibrillation are the same. They are not. SVT is usually regular; atrial fibrillation is irregularly irregular, has no consistent P waves, and carries a separate stroke risk that requires different management. Conflating them leads people to the wrong treatment assumptions.
Timeline: What Happens During an Episode
| Time point | PVC | SVT |
|---|---|---|
| 0 seconds | Ventricular focus fires early | Reentrant loop or rapid focus activates |
| 0 to 0.20 seconds | Wide QRS beat completes | Rate climbs to 150 to 250 per minute |
| Next 1 to 3 seconds | Compensatory pause, then normal beat resumes | Sustained fast rhythm continues |
| 10 to 30 seconds | Usually already over | Palpitations, lightheadedness may begin |
| 30 seconds to several minutes | Rarely recurs this fast | Symptoms peak; fainting possible above 200 per minute |
| Minutes to hours | Isolated episode | Episode may persist until broken or self-terminates |
| After the event | Person feels a thump and a pause | Abrupt return to normal rate; fatigue may follow |
The takeaway from the timeline is asymmetry. A PVC is over before most people can react to it. An SVT episode gives the body time to mount a stress response, which is why it is the rhythm more likely to prompt an emergency visit even when it is not more dangerous.
Red Flags That Change the Plan
Most palpitations are benign, but certain features demand urgent evaluation. These are the signs to treat as a bulleted warning list:
- Fainting or near-fainting during or right after a fast rhythm.
- Chest pain, shortness of breath, or sweating with palpitations.
- A fast rhythm that lasts more than 30 minutes without slowing.
- A known family history of sudden cardiac death or inherited arrhythmia.
- A very frequent, irregular pounding that wakes you from sleep or limits activity.
- Palpitations in someone with known structural heart disease, such as a prior heart attack or heart failure.
Any of these, per the 2017 ACC/AHA guideline for evaluation of syncope and palpitations, warrants prompt medical assessment rather than watchful waiting.
What to Actually Do
Start with documentation, not guesswork. A single office ECG captures only the moment, and most PVCs and SVT episodes are paroxysmal. A 14-day ambulatory monitor detects far more than a 24-hour Holter in people with infrequent symptoms, and a smartphone single-lead recording during an episode is often enough to classify the rhythm.
If you have infrequent PVCs and a structurally normal heart, the first move is lifestyle, not medication. Reducing caffeine, alcohol, and sleep deprivation cuts PVC frequency in many people. Correcting low potassium or low magnesium, when lab-confirmed, can help. Treating untreated sleep apnea has a measurable effect on nocturnal PVC burden.
If you have documented SVT, learn the vagal maneuvers your clinician approves. A Valsalva maneuver or carotid sinus massage, done safely, breaks roughly 20 to 40 percent of episodes. If episodes are frequent or disabling, catheter ablation for typical AV nodal reentrant tachycardia has a success rate above 90 percent and is often preferred over lifelong medication.
For symptomatic high-burden PVCs, catheter ablation is the definitive option when medications fail or are not tolerated. The decision hinges on burden percentage, symptoms, and whether the heart is structurally normal, which is why the numbers in this article matter more than the labels.
Limitations and Open Questions
Not everything here is settled. The exact threshold at which PVC burden causes cardiomyopathy varies between patients, and 10 percent is a clinical trigger, not a biological law. Some people tolerate a 20 percent burden without measurable decline, while others develop dysfunction at 10 percent. Why that variability exists remains an active research question.
The relationship between PVCs and SVT is also incompletely mapped. Vegetative triggers are clear; the genetic and structural factors that make one person's PVCs progress to sustained arrhythmia in another are not. And the evidence for lifestyle interventions rests on smaller studies than the evidence for ablation, so the certainty levels differ. Anyone weighing treatment should pair these numbers with an electrophysiologist's assessment, because the classification question, PVC versus SVT, is the easy part.